Two in five patients with heart failure (HF) have high inflammatory risk, with a similar prevalence across the spectrum of ...
LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...
Heart failure with preserved ejection fraction (HFpEF) is a condition in which the heart does not fill with blood properly. In HFpEF, the heart can pump normally, but the heart is stiff and cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results